COVID-19 has highlighted the cracks in our current healthcare systems, protocols, and policies. How can we address these vulnerabilities and what more can we look forward to in the years to come? The...
The new facility will be utilising the latest technology and equipment in viral vector and plasmid manufacturing to scale up its production capacity and deliver end-to-end cell and gene therapy...
A new, compact CRISPR-Cas system can now precisely and efficiently shuttle gene-editing tools into mammalian cells, overcoming present challenges in genome engineering. Most gadgets today are...
Bayer AG announced the acquisition of Asklepios BioPharmaceutical, Inc., a US-headquartered biopharmaceutical company specialized in the research, development and manufacturing of gene therapies...
Shinshu University and Toshiba have formulated a tumour-tropic liposome technology for transporting therapeutic genes into cancer cells. Toshiba Corporation and a team led by Professor Yozo Nakazawa...
A novel gene therapy that reprograms glial cells into neurons extends life span of mice with Huntington’s disease. Huntington’s disease is a fatal degenerative brain disorder caused by mutations...
In conjunction with the celebration was the graduation of its first cohort form the Graduate Certificate Programme in Pharmaceutical Regulation. CoRE was set up at Duke-NUS Medical School in 2014,...
Gracell Biotechnologies developes FasT CAR-T, a breakthrough technology for hematological malignancies. Gracell Biotechnologies, a China-based immune cell gene therapy company has developed a faster...
Collaboration to build global-standard platform for plasmid and virus manufacturing in China. A strategic alliance between pharma giant, Merck and Chinese biotech company, GenScript, aim to...
Mundipharma to bring Invossa-K to nine more countries in APAC. Mundipharma has acquired the exclusive rights for Invossa-K in Singapore, Malaysia, the Philippines, Thailand, Vietnam, Indonesia,...
